Saturday, 27 August 2022

AstraZeneca's Farxiga cuts death risk in heart failure patients -study

AstraZeneca's Farxiga cuts death risk in heart failure patients -study

AstraZeneca's blockbuster diabetes drug Farxiga led to significant reductions in the risk of hospitalisation and death in people with all types of heart failure, according to study data released on Saturday, opening the door to a substantial increase in patients who could benefit.

Abbott restarts Similac infant formula production at Michigan facility

Abbott Laboratories has restarted production of its Similac infant formula at the plant in Sturgis, Michigan at the center of the U.S. baby formula shortage.

Very few in the U.S. getting full monkeypox vaccine series - CDC chief

Very few people who have gotten monkeypox shots in the United States have received the second dose needed for full protection, U.S. Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky said on Friday.

3M combat earplug lawsuits to proceed, judge rules, despite bankruptcy case

3M Co must face more than 230,000 lawsuits accusing it of selling defective earplugs to the U.S. military, after a U.S. judge on Friday ruled that the bankruptcy of a subsidiary did not stop lawsuits against the non-bankrupt parent company.

Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine

Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic.

-LifeTalk_452px_236px.png
Sponsored by Roche: Global LifeTalk, Sep 5

Join the conversation! The event will feature Apl.De.AP, Dr Ratna Devi and Muniba Mazari in a panel discussion focused on improving access to healthcare in Asia.

FIND OUT MORE

Britain approves Novavax COVID shot for 12-17 year-olds

Britain's medicines regulator on Friday approved Novavax's COVID-19 vaccine for children aged between 12 and 17 years.

Novartis CEO may struggle to rally investors to Sandoz spin-off

Novartis CEO Vas Narasimhan could struggle to woo investors to the listing of generics drugs business Sandoz, as weaker drug prices and jittery financial markets present one of his biggest challenges in the years-long overhaul of the Swiss drugmaker.

China customs drops some COVID reporting for international arrivals; quarantine remains

China still requires international passengers to take pre-departure COVID-19 tests and quarantine upon arrival, the customs office said on Friday, a day after dropping some reporting requirements for travellers clearing customs.

Energy costs alarm Britons needing at-home kidney care

Sitting next to her dialysis machine which pumps clean blood around her body for four hours every day, Dawn White says she fears Britain's spiralling energy costs means she will no longer be able to afford the price of her life-saving treatment.

E.coli infections in four U.S. states rise to 84; majority Wendy's customers

The E.coli bacteria outbreak in four Midwest states from an unknown source has affected 47 more people, the U.S. Centers for Disease Control and Prevention said on Thursday, with a majority of the total 84 reported to have sandwiches at Wendy's .

Related Videos

New Ebola case confirmed in eastern Congo

Why has polio returned to the United States?

Mobile fridges keep vaccines cool in Kenya